Preserving Natures Design
We are developing uniquely disruptive technologies to revolutionise the spinal stabilisation market, commencing with three flagship pioneering, spinal devices. The Cervi-LOK™, GRASP Laminoplasty & Faci-LOK™
Read Our Profile
Disrupting
Current global spinal devices market estimated at $10.2 bn per annum and is expected to grow at a CAGR of 3.1% through 2026
Helping
1.62 million instrumented spinal procedures are carried out each year and North America currently accounts for approximately 54% of these
Transforming
Healthcare and indirect costs due to back pain are over $US12 billion per year
Management Team
TruSpine has a highly experienced management team with a background in medical device manufacture, sales, distribution and marketing in addition to market disruption and taking products from an idea to a successful commercialisation.
The medical advisory board has been assembled to complement the Company’s full time board and management team. It consists of highly qualified spinal surgeons and doctors from leading academic and medical institutions in Europe and the United States.